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A B S T R A C T
Changes in the two main intracellular degradation systems, the Ubiquitin-Proteasome System and the
Autophagy-Lysosome pathway (ALP) are widely discussed as a hallmark of the aging process. To follow the
age-related behavior of both degradation systems we examined their impact on ferritin, known to be degradable
by both. Ferritin H was analyzed in young and senescent human ﬁbroblasts, revealing a higher steady-state level
in the senescent cells. By blocking both proteolytic systems, we conﬁrmed that particularly the ALP plays a
crucial role in ferritin H turnover. However, an unexpected increase in lysosomal activity in the senescent cells,
suggests a dysregulation in the autophagy pathway. To further investigate the impaired ferritin H turnover,
confocal microscopic colocalization studies of ferritin H with lysosomal-associated membrane protein 2a
(Lamp2a) and monodansylcadaverine (MDC) were performed and clearly revealed the degradation of ferritin by
macroautophagy. By induction of autophagy via inhibition of mTOR using rapamycin an increase of ferritin H
turnover was obtained in senescent cells, demonstrating a mTOR dependent reduction of autophagy in
senescent human ﬁbroblasts.
1. Introduction
Degradation of modiﬁed and damaged proteins is an essential
process for maintaining cellular functions and viability. It is known that
several repair and antioxidant mechanism gradually decline during the
aging process [1,2]. Furthermore, it is assumed that the production of
reactive oxygen species, which varies greatly during diﬀerent stages of
life [3–5], additionally aggravate the decline of cellular defense
mechanisms, such as catalase, glutathione peroxidase [6] and super-
oxide dismutase [7,8]. Dysfunction of regular proteolysis leads to
increased accumulation of oxidized proteins and serious functional
consequences, since proteins act as receptors, transcription factors and
enzymes. In addition, these modiﬁed and damaged proteins can cross-
link and form protein aggregates, involved in many age-related
diseases [9]. For intracellular protein turnover cells possess two major
proteolytic systems: the Ubiquitin-Proteasome System (UPS) and the
Autophagy-Lysosome pathway (ALP) [10]. Among its various func-
tions, a major role of the UPS, more precisely the 20S proteasome, is
the degradation of unfolded, oxidized and short-lived proteins, pre-
venting their accumulation [11–13]. Additionally, the 26S proteasome
of the UPS is able to speciﬁcally degrade ubiquitin-labeled proteins,
demonstrating the selectivity of the UPS [14]. The ALP involves the
engulfment of cytoplasmic material, such as organelles or long-lived
proteins and the delivery of sequestered cargo into the lysosomes
followed by their degradation. For the transfer to the lysosomes three
diﬀerent types of autophagy are well described. One is the chaperone-
mediated autophagy (CMA) responsible for the speciﬁc delivery of
soluble cytosolic proteins. Additionally to CMA, two other types of
autophagy are known, microautophagy and macroautophagy. During
macroautophagy a de novo- membrane is formed which further extend
to a double-membrane vesicle, the so-called autophagosome. The
autophagosome then fuses with the lysosome to form the autolyso-
some, where the degradation of the cell constituents by diﬀerent
cathepsins takes places. In order to clarify the degradation of ferritin
by macroautophagy, colocalization of the protein with autophago-
somes, via MDC, or Lamp2a, indicating an involvement of CMA, can
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be performed. Furthermore, macroautophagy has been described to be
negatively regulated by mammalian target of rapamycin 1 (mTORC1)
[15]. One way to verify that autophagy is responsible for ferritin
turnover is the inhibition of mTOR, especially mTORC1 (referred to as
mTOR from here on). It is well-known that mTOR can suppress
autophagy and that its inhibition via rapamycin leads to an induction
of autophagy [16,17]. To directly study the age-related changes in
intracellular protein turnover we used a cytosolic protein, ferritin H,
which is known to be degraded by both proteolytic systems, the UPS
[18,19] and ALP [20,21]. In mammalian cells the cytosolic iron storage
protein ferritin plays a crucial role in iron metabolism. It is composed
of 24 protein subunits, which are divided into two isoforms, ferritin
light chains and ferritin heavy chains. The ferroxidase activity of
ferritin H oxidizes free Fe2+ to Fe3+ and thus stores it safely. In the
event of cellular iron deﬁciency, iron can be released from ferritin
again. In the presence of reactive oxygen species, such as superoxide
and hydrogen peroxide, free iron can catalyze highly reactive hydroxyl
radicals via the Fenton reaction, which are able to damage lipids,
proteins and DNA. Therefore, a strict regulation of iron uptake, storage
and release is essential for maintaining cellular homeostasis. Hence
turnover of ferritin H can bring further information in the changes and
compensatory mechanisms of the proteolytic systems during aging and
on the other hand it will give further insight in the ferritin H turnover.
While, recent reports already described a more speciﬁc degradation of
ferritin H via autophagy in knock-out and knock-down systems [22],
this study compares the changes of ferritin turnover in young and
senescent cells, demonstrating that reduced autophagy is responsible
for impaired ferritin turnover in senescent human ﬁbroblasts.
2. Results
2.1. Protein and mRNA expression of ferritin H in young and in vitro
aged ﬁbroblasts
To monitor the age-related changes in the proteolytic systems we
performed all subsequent experiments in young (up to PD20) and
senescent ﬁbroblasts (up to PD60, referred to as old from here on), an
aging model already described in [23]. To conﬁrm cellular senescence
we analyzed morphological diﬀerences, x-Gal staining, where 70.8% of
the old cells were positive for SA-β-Gal, formation of protein carbonyls
[24], lipofuscin accumulation [25], Ki67 and p16 (Fig. 1). The
combination of all these parameters clearly demonstrates the senes-
cence state of the old ﬁbroblasts, necessary for all ongoing experiments.
To show that apoptosis is not aﬀecting our senescence model, we
additionally determined caspase-3/7 activity in young and old cells
(Fig. 1B). By analyzing the ferritin H amount in ﬁbroblasts with
diﬀerent population doublings we interestingly monitored signiﬁcant
higher basal levels of the protein via immunoblot (Fig. 2A) and
ﬂuorescence microscopy (Fig. 2B) in the old cells. To examine whether
the higher quantity of ferritin H results from an increased protein
Fig. 1. Determination of senescence parameters in human ﬁbroblasts. To verify senescence of the old ﬁbroblasts, the following senescence-associated parameters were
determined: (A) diﬀerences in morphology by transmitted light microscopy, (B) levels of caspase 3/7 activity, (C) X-gal staining for senescence associated β-galactosidase (70.8% of old
cells are positive for SA-β-Gal) (D) quantiﬁcation of protein carbonyls in young and old cells and (E) quantitative analysis of ﬂuorescent aging pigment lipofuscin, (F) Ki67 and (G) p16
staining. Data for (D) were normalized to Ponceau S staining and shown in percentages to the young control. The data represent the mean ± SD of at least three independent
experiments. In general, statistical signiﬁcant diﬀerences between young and old cells were evaluated by student's t-test and are shown by *p < 0.05 and **p < 0.01 compared to the
young.
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expression or accumulation of non-degraded ferritin H, we tested the
inducibility of ferritin H in young and old cells, using a hemin solution
with a ﬁnal concentration of 7 µM. Hemin was able to signiﬁcantly
increase levels of ferritin H mRNA (Fig. 3A) and protein expression
(Fig. 3B) in young cells 24 h after addition. By comparing young and
old cells we detected a slighter increase of ferritin H in the old cells.
2.2. Determination of ferritin H turnover after incubation with hemin
and deferoxamine
In order to analyze the degradation of ferritin in young and old
ﬁbroblasts, we quantiﬁed the amount of ferritin H in a model of ferritin
turnover. To obtain such a model, we ﬁrst treated the cells with hemin
for 24 h, to induce ferritin H, and removed hemin afterwards. After
removal of hemin, the ferritin H content was analyzed at diﬀerent time
points. A signiﬁcant decrease of ferritin H was detected 24 h after
hemin removal (Fig. 4A). However, protein turnover was much more
pronounced in young cells compared to senescent ones. Furthermore,
after 36 h no further decrease of ferritin H in old cells was detectable
(data not shown), excluding that the time interval might not be
adequate. Basically, several reasons for this phenomenon might exist:
(i) there might be a higher iron content in old cells, therefore, requiring
higher ferritin H levels; or (ii) the proteolytic systems might be
inadequate. In order to address the possibility that the high level of
ferritin H is due to the high amount of iron, we treated the young as
well as old cells with deferoxamine (DFO). deferoxamine, as a well-
known iron chelator, should reduce cellular iron content and, there-
fore, reduce the required ferritin H levels. As shown in Fig. 4A,
deferoxamine incubation for 24 h is able to decrease the ferritin H
level in young cells. However, in senescent cells deferoxamine fails to
do so: the ferritin H level was not aﬀected by deferoxamine. Thus, a
signiﬁcantly reduced ability to degrade ferritin H in old cells, indepen-
dently of the iron status, was detected.
2.3. Eﬀects of lysosomal and proteasomal inhibitors on ferritin H
turnover
In order to test for the contribution of the major proteolytic systems
to the degradation of ferritin, we used two selective inhibitors of both
pathways. For blocking the 20S proteasome (20S) activity we used the
inhibitor Lactacystin (LC). To block the lysosomal activity we incubated
cells with Concanamycin A (ConA). As described above, cells were ﬁrst
pretreated with hemin for 24 h, followed by the removal of hemin for
another 24 h. During the latter period the proteolysis inhibitors were
Fig. 2. Steady state levels of ferritin H in young and old human ﬁbroblasts.
(A) Ferritin H was analyzed in cell lysates by immunoblotting. Quantiﬁcation of ferritin H
at MW of 21k Da was performed in relation to the reference protein GAPDH. Data are
shown for steady state levels of ferritin H in young and old cells. (B) Fluorescence
microscopy image of stained ferritin H in young and old control cells. Panel (A) data
represent the mean ± SD of at least seven independent experiments. Statistical signiﬁcant
diﬀerences between two groups were evaluated by student's t-test and are shown by *p <
0.05. Panel (B) data represent the mean ± SD of at least three independent experiments
(90 cells each).
Fig. 3. Induction of ferritin H in young and old human ﬁbroblasts. Young and old cells were exposed to hemin for ferritin H induction for 24 h. Relative ferritin H (A) mRNA
levels and (B) protein levels are shown after 24 h of hemin exposure. To emphasize the eﬀects on ferritin H mRNA expression, we respectively set time point “0 h after hemin” at 100% in
young and old cells. In addition, small diagrams are included, depicting the direct comparison between young and old controls. Data shown for mRNA expression levels were normalized
by mRNA expression levels of GAPDH. Quantiﬁcation of ferritin H protein levels was performed as described in Fig. 2A. The data represent the mean ± SD of at least three independent
experiments. Statistical signiﬁcant diﬀerences between controls and treated cells were calculated, using one-way ANOVA, followed by Tukey's post hoc test and are shown by */# p <
0.05, compared to the corresponding controls.
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added. The proteasomal inhibitor LC did not inﬂuence the degradation
of ferritin H (Fig. 4B). However, inhibition of the lysosomal activity via
ConA revealed higher ferritin H levels in both young and old cells.
Since, ferritin H degradation is largely mediated by the lysosomal
system in young and senescent cells and only to a minor part by the
proteasomal system, the fact that ferritin H degradation is reduced in
old cells, consequently leads to the question how active both proteolytic
systems are in senescent cells. To examine these, we measured the
maximal proteolytic activities in young and old cells. For the 20S
activity a signiﬁcant decrease of chymotrypsin-like activity (β5-sub-
unit) was detectable in old cells, compared to the young ones (Fig. 5A).
Detection of lysosomal activity was performed by using speciﬁc
substrates for cathepsins B & L as well as D &E (Fig. 5B/C). Most
interestingly, we have found an increase of the activity of these major
cathepsins in our senescence model. This seems contradictorily, since
we also detected a decline of the turnover of ferritin H.
Fig. 4. Protein turnover of ferritin H and inﬂuence of proteasomal and lysosomal inhibitors. In panel (A) young and old ﬁbroblasts were exposed to hemin for 24 h,
afterwards hemin was removed. Cells were harvested 0 h after hemin incubation as well as after another 24 h without (24 h after hemin) and with iron-chelator deferoxamine (24 h
DFO). Data are shown in relation to the reference protein GAPDH. In panel (B) cells were also treated for 24 h with hemin. After removing hemin cells were treated 24 h with the
proteasome inhibitor Lactacystin (24 h LC), the lysosomal inhibitor Concanamycin A (24 h ConA) or both inhibitors (24 h LC + ConA). To emphasize the eﬀects on ferritin H turnover
and potential inﬂuences of the inhibitors even more, we respectively set time point “0 h after hemin” at 100% in young and old cells. Statistical signiﬁcant diﬀerences between controls
and treated cells is shown by */# p < 0.05. The data represent the mean ± SD of at least three independent experiments and statistical signiﬁcant diﬀerences between controls and treated
cells were calculated, using student's t-test and are shown by */# p < 0.05, compared to the corresponding controls..
Fig. 5. Measurement of lysosomal and proteasomal activities and quantiﬁcation of Lamp1. Untreated young and old cells were used for the analyses as described in the
methods section. (A) Proteasomal activity was measured using ﬂuorogenic substrates for the β1, β2 and β5 catalytic subunits, respectively. Measurement of lysosomal cathepsin activities
was carried out by using substrates speciﬁc for cathepsins D& E (panel B) and L & B (panel C) (for details see methods). Relative amount of Lamp1 was quantiﬁed via immunoblotting,
again in relation to the reference protein GAPDH (panel D). Also in panel D representative immunostaining of Lamp1 in young and old cells is shown. Data are displayed as percentages
in relation to the young control (A-D). Data represent the mean ± SD of at least three independent experiments and statistical signiﬁcance diﬀerences between young and old controls
were calculated, using student's t-test and are shown by *p < 0.05, compared to the young control.
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Fig. 6. Confocal microscopic colocalization study of ferritin H with Lamp2aa or MDC and ﬂuorescence microscopic analysis of LC3. For colocalization analyses via
confocal microscopy 40,000 cells were seeded on glass bottom dishes 24 h before staining with the respective primary and secondary antibodies immediately followed by confocal
microscopic examination using confocal microscope “LSM780” from Zeiss. (A) The weighted colocalization coeﬃcient, generated by the ZEN-software package of the Zeiss “LSM780”,
was calculated by the sum of intensities of colocalizing pixels for ferritin H with Lamp2a or monodansycadaverine (MDC) in comparison to the overall sum of pixel intensities for ferritin
H. In the young control cells 18% of ferritin H was colocalized with Lamp2a and 70% of ferritin H was colocalized with MDC. In the old control cells 49% of ferritin H was colocalized
with Lamp2a, while 90% of ferritin H was colocalized with MDC. (B) Representative images of each colocalization. (C) Microscopic analysis of LC3 in young and old cells. Data were
presented as ratio of LC3 with inhibitor Concanamycin A (LC3 Cona) to LC3 in controls (LC3 control). All data represent the mean ± SD of at least three independent experiments (at
least 30 cells each).
Fig. 7. Decrease of ferritin H levels in rapamycin treated in senescent ﬁbroblasts and mTOR quantiﬁcation in young and old ﬁbroblasts. Panel (A) shows the eﬀect
of rapamycin on the autophagy-associated protein LC3, depicted as LC3-II/LC3-I ratio, in dependency of Concanamycin A (ConA). Panel (B) shows the inﬂuence of rapamycin on the
degradation of ferritin H in old cells, compared to young and old controls. Panel (C) demonstrates the protein amount of mTOR protein in young and old ﬁbroblasts. All data were
analyzed in relation to GAPDH and data are shown as percentages in relation to (A) control or (B) young control. The data represent the mean ± SD of at least three independent
experiments. Statistical signiﬁcant diﬀerences between controls and treated cells were calculated, using one-way ANOVA, followed by Tukey's post hoc test and are indicated by * p <
0.05, ** p < 0.01 compared to the controls.
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2.4. Confocal microscopy colocalization studies to clarify the role of
CMA or macroautophagy in reduced ferritin H degradation in aging
To further test if CMA or macroautophagy are responsible for the
age-related changes in ferritin H degradation, we also performed
confocal microscopy colocalization analyses for ferritin H with
Lamp2a or the autophagosome marker MDC (Fig. 6). Therefore, the
weighted colocalization coeﬃcient generated by the ZEN-software
package from Zeiss; calculated by the sum of intensities of colocalizing
pixels for ferritin H with Lamp2a or MDC in comparison to the overall
sum of pixel intensities, was analyzed. Due to the results only 18% of
ferritin H was colocalized with Lamp2a, meanwhile 71% were asso-
ciated with MDC in the young cells, suggesting that ferritin H turnover
is mainly performed by macroautophagy. The increase in the coloca-
lization factors for ferritin H to Lamp2a (49%) and FTH to MDC (90%)
in the old cells can be explained by the higher ferritin H levels in the old
cells. In addition to the autophagosome staining by MDC, we also
analyzed the ratio of LC3 in comparison to a lysosomal inhibitor
Concanamycin A (ConA) (Fig. 6C). The ratios between LC3 ConA to
LC3 control show that more LC3 is formed in the young cells.
2.5. Induction of autophagy by rapamycin in young and senescent
ﬁbroblasts
To clarify a potential involvement of mammalian target of rapamy-
cin (mTOR) in downregulating of macroautophagy, additionally ex-
plaining the reduced ferritin H turnover in old ﬁbroblasts, we further
treated the cells with rapamycin. According to the literature [26,27], we
chose a ﬁnal concentration of 100 nM to induce the degradation of
ferritin H in old ﬁbroblasts (Fig. 7). To demonstrate, whether autop-
hagy is aﬀected by rapamycin, we analyzed the protein microtubule-
associated protein 1A/1B-light chain 3 (LC3) in old rapamycin treated
cells. As shown in Fig. 7A, rapamycin leads to an increased LC3-II
formation, compared to the ConA control. To prove that this autophagy
inducer also leads to increased ferritin degradation in old cells, we
additionally quantiﬁed ferritin H in rapamycin treated cells and
compared the ferritin H levels with those from the young and old
controls. As Fig. 7B demonstrates in rapamycin-treated old cells,
ferritin H was reduced to comparable low levels as in young ﬁbroblasts.
Additionally, reduction of ferritin H in young cells after rapamycin
treatment conﬁrmed that induced autophagy is involved in ferritin H
turnover (Fig. 7C).
3. Discussion
In general, cellular aging is characterized as an ongoing process
with a progressive loss of cellular maintenance and a decrease of repair
and turnover systems, resulting in aggregation and accumulation of
proteins [9]. Increasing amounts of non-degradable aggregates, such as
lipofuscin [25,28,29] or advanced glycation end products [30,31], in
turn are able to aﬀect intracellular proteolytic processes and lead to a
vicious cycle in protein aggregate accumulation. To obtain more
information about the changes in proteolytic activity during the aging
process, we followed the ferritin H turnover in young and senescent
ﬁbroblasts. We were able to demonstrate a higher amount of ferritin H
in senescent cells, suggesting either an increased expression or a
decreased degradation of the ferritin subunit. Since we were able to
rule out an enhanced ferritin mRNA-expression in the old cells
compared to the young ones, it leads us to the assumption of an
impaired degradation rate of the protein. In order to exclude an
inﬂuence of the amount of iron on the slow ferritin H degradation
rate, we treated the cells with the iron chelator deferoxamine.
Analyzing the normalization of induced ferritin H levels after a hemin
stimulation in young and old cells it became apparent that the
degradation in old cells is slower, compared to young ones.
According to previous reports that ferritin H is degraded by the 20S
proteasome as well as by the ALP, we tested both systems for the
inﬂuence on ferritin degradation in aging. Inhibition of both proteolytic
systems showed that ferritin H is mainly degraded by the lysosomal
machinery, as it was already reported for other cellular models [20,21].
Moreover, in the condition of UPS inhibition by LC, degradation of
ferritin H seems to be further increased, assuming a potential up-
regulation of the lysosomal activity. During cellular senescence, a
decline of 20S activity is known in ﬁbroblasts, previously reported
already by our group [9,29,32] and others [2,5] in diﬀerent models,
while the activity of the lysosomal system was rather increased. Similar
results have already been reported by Höhn et al., demonstrating an
increase in area and number of lysosomes per cell [33]. While several
studies described that lysosomal activity increased in old cells [34,35],
others obtained opposite eﬀects [36,37]. However, in our model the
activity of the major cathepsins D/E and L/B was separately tested and
both are increased in old cells. This might be due to compensatory
reasons, since several studies have proposed a crosstalk between the
UPS and the ALP, demonstrating up-regulation of lysosomal activity
during impairment of the UPS [38,39]. Since, the maximal cathepsin
activity is not able to explain the decreased degradation rate of ferritin
H in the old cells; we further investigated the role of chaperone-
mediated autophagy, via Lamp2a, and macroautophagy, via autopha-
gosome staining by monodansylcadaverine (MDC), on impaired ferritin
turnover. For this purpose, we performed confocal microscopy coloca-
lization analyses for ferritin H with Lamp2a and ferritin H with MDC
(Fig. 6). The results clearly showed that the overall turnover of ferritin
H in young cells is carried out by macroautophagy, demonstrated by
71% of ferritin H colocalized with MDC compared to 18% of ferritin H
colocalized with Lamp2a. The increase in colocalization of ferritin H to
Lamp2a or MDC in the old cells can be explained by the increased
ferritin H that we detected in old cells. The more ferritin H is present,
the more ferritin H can be colocalized with either Lamp2a or MDC.
However, the results showed that chaperone-mediated autophagy plays
no major role in ferritin H turnover. Furthermore, it is demonstrated
that not only the initial steps of autophagy are reduced; since
accumulation of ferritin H in autophagosomes indicates a reduced
turnover of the protein. The results even more suggest a reduced fusion
of autophagosomes with the lysosomes, which needs to be further
investigated. Additionally, by quantifying LC3 via microscopic studies,
comparing control cells to cells pretreated with lysosomal inhibitor
Concanamycin A, we were able to show a decreased formation of LC3
in the old cells, compared to the young ones. Decreased levels of LC3
have already been reported and support the impairment of autophagy
in aging [40,41]. Several studies have shown that besides ferritin H
degradation by the proteasome [18,19], turnover of ferritin H is mainly
mediated by lysosomal hydrolyses assuming increased ferritin H levels
when parts of the Autophagy-Lysosome pathway (ALP) are inhibited
[20,21,42,43]. Recent studies have reported that particularly macro-
autophagy plays a crucial role in ferritin H removal [22,44]. Besides
decreased levels of LC3 in comparison to a lysosomal inhibitor control,
increased levels of ferritin H suggest a decline of autophagy in the aged
cells. To clearly demonstrate that autophagy is responsible for impaired
ferritin H degradation, the next experiments should answer the
questions i) whether an induction of autophagy in old cells is possible
and ii) if the induced autophagy can reduce the ferritin H levels in the
old cells to the level of the young cells. As demonstrated in Fig. 7, we
were able to show rapamycin-induced macroautophagy by increased
formation of LC3-II (Fig. 7A). These results suggest that autophagy can
be induced in old cells and that mTOR also aﬀects the formation of
LC3-II. In comparison with the old controls, rapamycin-treated old
cells showed decreased levels of ferritin H (Fig. 7B), demonstrating that
impaired autophagy is responsible for the reduced ferritin H degrada-
tion.
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4. Conclusion
In summary, our results showed that the ferritin H turnover in
young and old human ﬁbroblasts is largely catalyzed by the lysosomal
system and is reduced in old cells. Due to the fact that the amount of
lysosomes and their activity, measured by cathepsin D/E as well as B/L
activity, were higher in the old cells, we conclude that uptake into
lysosomes is likely to be impaired in aging, supported by the confocal
microscopic colocalization studies of ferritin H and MDC as well as the
decreased LC3 formation. Since rapamycin leads to an induction of
autophagy and to increased ferritin H turnover in old cells, our
assumption that autophagy is impaired in the senescent cells was
conﬁrmed. Finally, all data implicate that autophagy plays a major role
in degradation of cytosolic proteins, such as ferritin H and that its
impairment can be decisive for protein accumulation during the aging
process. Further investigations of the ALP to answer the still open
questions on the inverse eﬀect ot mTOR on ALP initiation and other
aﬀected proteins would be interesting counteract impaired protein
turnover and protein aggregation in aging and aged-related diseases.
5. Materials and methods
5.1. Cell culture
Cell culture materials were obtained from Biochrom and all other
chemicals were purchased from Sigma-Aldrich unless otherwise speci-
ﬁed. Human dermal ﬁbroblasts were obtained from human foreskin
tissue of a 1-year old donor, kindly provided by Prof. Scharﬀetter-
Kochanek from the University of Ulm, Germany. Fibroblasts were
grown in DMEM, supplemented with 10% fetal bovine serum (FBS)
and 1% L-glutamine. Cells were kept in 5% CO2 at 37 °C and 95%
humidity and passed once a week, when reaching 85% conﬂuency. Cells
with population doublings (PD) up to 20 were deﬁned as “young cells”
and senescent cells from a PD of 60 as “old” cells. Inhibition of 20S
activity was performed using the speciﬁc inhibitor Lactacystin (LC,
Sigma-Aldrich, L6785) at a ﬁnal concentration of 20 µM. For blocking
the lysosomal activity we used Concanamycin A (ConA, Sigma-Aldrich,
C9705) at a ﬁnal concentration of 250 nM. Determination of apoptosis
in young and old ﬁbroblasts was performed using the ApoTox-Glo™
Triplex Assay (Promega, G6320). Additionally, x-gal staining was
performed, using Senescence β-Galactosidase Staining Kit (Cell signal-
ing, #9860), according manufactures instructions.
5.2. Cell treatment with hemin, deferoxamine and rapamycin
Hemin solution was prepared by using hemin (Sigma-Aldrich,
H51280) solved in 0.1 M NaOH to obtain a 25 mM stock solution.
The fresh hemin stock solution was diluted with medium to obtain a
ﬁnal concentration of 7 µM. Fibroblasts were incubated with hemin for
various time intervals (data not shown), but ﬁnal experiments were
performed with 24 h hemin incubation. To examine the ferritin H
response, cells were also incubated with deferoxamine (Sigma-Aldrich,
D9533). Deferoxamine solution was prepared by using deferoxamine
mesylate salt solved in PBS to obtain a 2 mM stock solution, followed
by a dilution with medium to a ﬁnal concentration of 100 µM. To
induce autophagy, cells were treated with rapamycin. Rapamycin
solution was prepared by diluting the rapamycin ready-made solution
(Sigma-Aldrich, R8781) with medium to a ﬁnal concentration of
100 nM.
5.3. Quantitative real-time PCR (qPCR) of ferritin H
RNA was extracted from ﬁbroblasts using the RNeasy Mini Kit
(Qiagen, 74104) according to the manufacturer. RNA integrity was
examined by using Agilent Analyzer (Biometra, Goettingen, Germany)
and RNA concentration was carried out by using spectrophotometer
NanoDrop (ND-1000, G & P Commercial Enterprises GmbH,
Saarbrücken). Following, total RNA (1 µg) was transcribed into cDNA
using Superscript II (10.000 units, Thermo Fisher, 18064-014), 10 mM
DNTP Mix (Thermo Fisher, R0191), 1 M dithiothreitol (DTT), Oligo
(DT)12–18 Primer (Thermo Fisher, 18418-012), and RNase H (5000 U/
ml) (New England Biolabs, M0297S). Quantitative real-time PCR was
carried out in 30 cycles, each at 94 °C, afterwards 55 °C for 30 s,
completed with 72 °C for 30 s. The reaction-mix included 10 mM dNTP
Mix 5 U/µl GoTaq DNA-Polymerase, Green Buﬀer (Promega, M3171)
and the speciﬁc primers at 10 pmol. For the qPCR the iCycler IQ
Multicolor Real time PCR Detection System (BioRad, 218073) was
used. The respective primers were synthesized by biomers.net (Ulm,
Germany) using the following sequences: ferritin H ‘5` ggg gtt tcc ttt
acc ttt tct 3′ and 5′ ggc act taa gga atc tgg aag 3′; GAPDH 5′
atgacatcaagaaggtggtga 3′ and 5′ cca aat tcg ttg tca tac cag 3′as well
as actin-β 5′ agg atg cag aag gag atc act3′ and 5′ aag aaa ggg tgt aac gca
act 3′. Gene expression was quantiﬁed by the corresponding cycle
threshold (Ct) value for each sample, taking account the PCR eﬃciency,
resulting from the data analyses module of the iCycler system. Two
diﬀerent housekeeping genes, GAPDH and actin-β were used. To
perform qPCR analyses we used the iQ™ SYBR® Green Supermix from
BioRad (BioRad, 1708880). Ferritin H was normalized to the ration of
GAPDH. As a template for the internal standard we used pooled cDNA
of our samples, generating a tenfold dilution series over four points,
starting with the most concentrated cDNA sample. For all standards
and samples, a qPCR protocol was performed in triplicate for all primer
pairs of interest.
5.4. Measurement of 20S proteasome activity
For the measurement of 20S activity cells were harvested and
centrifuged for 5 min at 500×g. In the following, cells were lysed in
1 mM DTT using a syringe and further incubated 1 h at 4 °C under
vigorous shaking. Afterwards, lysates were centrifuged for 10 min at
20,000×g and supernatants were used for the measurement of 20S
activity or for the determination of protein concentration. For the
activity measurement centrifuged cell lysates were incubated in
225 mM Tris buﬀer (pH 7.8), 7.5 mM magnesium chloride, 7.5 mM
magnesium acetate and 1 mM DTT. As substrates for proteasome
activities we used substrate Z-Leu-Leu-Glu-AMC for peptidyl-glutamyl-
like activity (β1) (Boston Biochem Cat. S-230), substrate Ac-Arg-Leu-
Arg-AMC for trypsin-like activity (β2) (Boston Biochem Cat. S-290)
and suc-LLVY-AMC for chymotrypsin-like activity (β5) (AMC, Sigma-
Aldrich, S6510) which were added to the samples for 30 min at 37 °C.
Measurement of AMC (Enzo, BML-KI107-0001) liberation was per-
formed with a ﬂuorescence reader at λex 360 nm and λem 460 nm.
5.5. Measurement of lysosomal activity
Determination of lysosomal activity was previously described by
Sitte et al. [45]. For preparation cell lysates were incubated for 1 h in
1 mM DTT at 4 °C under vigorous shaking. Afterwards, lysates were
sonicated for 2 min on ice, using Sonoplus GM70 (Bandelin). In the
following, cells were centrifuged for 20 min at 20.000×g and the
supernatant was taken for determination of protein concentration via
a Bradford assay (BioRad, 5000006) and the measurement of lysosomal
activity. To analyze the lysosomal activity, substrates for cysteine
cathepsins B & L (Enzo, Z-FR-AMC) and for aspartic acid cathepsins
D&E (Enzo, BML-P145) were used. Lysates were incubated in 8 mM
cysteine-hydrochloride, 50 mM sodium acetate and 1 mM EDTA pH
4.0% and 0.2% 0.5 M DTT, followed by incubation with the substrates
for 30 min at 37 °C. For analysis of cathepsins B & L activity, measure-
ment of AMC liberation was determined with a ﬂuorescence reader at
λex 360 nm and λem 460 nm. For cathepsins D&E activity, the substrate
7-methoxycoumarin-4-yl-acetyl-(dinitrophenyl)-RNH2 (MOCA, Enzo,
P-127) was used and MOCA liberation was measured at λex 360 nm
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and λem 460 nm. The liberation of MOCA and AMC was determined by
a calibration curve with MOCA and AMC standards.
5.6. Immunoblot analysis
For quantiﬁcation of the respective protein concentrations, controls
and treated cells were harvested, lysed and protein concentration was
measured by Bradford or Lowry assay (BioRad, 5000111), according to
the lysis buﬀers. Further, 20–35 µg protein lysate was added to
Laemmli buﬀer (0.25 M Tris (pH 6.8), 40% glycerol, 8% SDS, 0.03%
Orange G (Carl Roth, 0318.2)) and separated using a 12 or 15%
acrylamide gel SDS-PAGE (BioRad, Munich, Germany). Afterwards,
proteins were transferred to nitrocellulose (VWR, 10600002) or
polyvinylidene diﬂuoride (Millipore, 372,93) membranes.
Subsequently, blots were blocked in Odyssey© blocking buﬀer (LI-
COR Biosciences, 927–40003) for 1 h at RT, followed by the incubation
with primary antibodies for 1 h with dilutions recommended by the
manufacturer. For immunodetection, the following antibodies were
used: mouse monoclonal ferritin H (Abcam, ab77127) and additionally
for analyzing the murine brain samples rabbit monoclonal ferritin H
(Cell signaling, 3998S). Furthermore rabbit and mouse monoclonal
GAPDH (Abcam, ab8245, ab37168), rabbit monoclonal Lamp1
(Abcam, ab108597) and LC3 (speciﬁcally recognizes LC3-I at 18 kDa
and LC3-II at 16 kDa purchased from NanoTools, 0231-100).
Fluorescent-conjugated secondary antibodies were obtained from LI-
COR Biosciences and were used according to the speciﬁcations of the
manufacturer. Membranes were scanned and quantiﬁed with the
Odyssey Infrared Imaging System and blot quantiﬁcations were carried
out using the Image Studio™ Software (LI-COR, Biosciences). Due to
the instructions of the manufacturers data for the images were capture
across a dynamic range without image saturation, “blowout”, or
sacriﬁcing sensitivity.
5.7. Protein carbonyl immunoblot
To quantify protein carbonyls by immunoblot analysis, membrane-
bound protein carbonyls were derivatized by 2,4-dinitrophenylhydra-
zine [24], leading to the formation of dinitrophenylhydrazone products
(DNP) which can be detected by an anti-DNP antibody (Sigma-Aldrich,
D9656).
5.8. Detection of p16, Ki67, ferritin H, Lamp1 and LC3 via
immunoﬂuorescence microscopy
40,000 cells were seeded on glass bottom dishes (MatTek
Corporation) 24 h before staining. After incubation cells were washed
with PBS and ﬁxed with a mixture of ethanol and diethylether (1:1, v/v)
for 6 min at −20 °C. Afterwards, cells were washed with PBS containing
1% FCS (PBS/FCS), followed by blocking for 30 min at RT in PBS/FCS.
Subsequently, cells were incubated with the primary antibodies (di-
luted 1:100 in PBS) for 2 h at RT. The following primary antibodies
were used: mouse monoclonal p16 (Abcam, ab54210), rabbit mono-
clonal Ki67 (Abcam, (ab16667), rabbit monoclonal ferritin H (Cell
signaling, 3998S), mouse monoclonal Lamp1 (Abcam, ab25630) and
rabbit monoclonal LC3A/B ( Cell signaling, c 12741). Afterwards, cells
were washed and further incubated with the secondary ﬂuorescence-
labeled antibodies FITC (1:100 in PBS) and TRITC (1:200 in PBS) for
1 h at RT, followed by three washing steps and immediate ﬂuorescence
microscopic examination (Invitrogen, AlexaFluor A21206, A11008,
A11020). Quantiﬁcation of single cells was performed via Corel
Photo-Paint X3 by the following calculation: mean ﬂuorescence
intensity minus background ﬂuorescence multiplied with pixel number
of the area of the cells.
5.9. Confocal microscopic colocalization study of ferritin H with
Lamp2a or MDC
For colocalization analyses via confocal microscopy 40.000 cells
were seeded on glass bottom dishes 24 h before staining with ferritin H
antibody (Abcam, ab77127, cell signaling #3998), Lamp2a (Abcam,
ab125068) and monodansylcadaverine (MDC) (Sigma 30432). For
ferritin H and Lamp2a antibody, incubation was performed as men-
tioned for the immunoﬂuorescence. For MDC staining, cells were
incubated with 0.05 mM MDC at 37 °C for 15 min, immediately
followed by ﬁxation, as described before. Microscopic examinations
were performed using the confocal microscope “LSM780” from Zeiss.
Evaluation of colocalization was done with the ZEN-software package
of the Zeiss “LSM780”, calculating the sum of intensities of colocalized
pixels for ferritin H with Lamp2a or monodansycadaverine (MDC) in
comparison to the overall sum of pixel intensities for ferritin H. The
data represent the mean ± SD of at least three independent experi-
ments (90 cells each).
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